Janus Henderson Investors US’s Amicus Therapeutics FOLD Stock Holding History

Janus Henderson Investors US’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$50.9M	Buy	7,136,697 +244,906	+4%	+$1.55M	0.04%	443
2016 Q4	$34.3M	Sell	6,891,791 -816,289	-11%	-$5.65M	0.03%	514
2016 Q3	$57M	Buy	7,708,080 +2,145,714	+39%	+$14.5M	0.05%	406
2016 Q2	$30.4M	Sell	5,562,366 -54,142	-1%	-$379K	0.03%	507
2016 Q1	$47.5M	Buy	5,616,508 +522,074	+10%	+$3.7M	0.04%	439
2015 Q4	$49.4M	Buy	5,094,434 +842,580	+20%	+$7.59M	0.04%	425
2015 Q3	$59.5M	Buy	4,251,854 +1,344,193	+46%	+$21.1M	0.05%	377
2015 Q2	$41.1M	Buy	+2,907,661	New	+$35M	0.03%	476

Other funds holding FOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Investors US's FOLD Position: Q1 2017 in Review

Janus Henderson Investors US increased its Amicus Therapeutics (FOLD) stake by 3.6% in Q1 2017, buying an estimated $1.55M and bringing the position to 7,136,697 shares worth $50.9M. The position accounts for 0.04% of the portfolio, ranked #443.

Janus Henderson Investors US first reported a position in FOLD in Q2 2015 and has held it in 8 quarters since. The position peaked at $59.5M in Q3 2015. 134 funds tracked by Wall St. Rank hold FOLD as of Q1 2017.

Janus Henderson Investors US held 7,136,697 shares of Amicus Therapeutics worth $50.9M as of Q1 2017.
Janus Henderson Investors US bought 244,906 Amicus Therapeutics shares in Q1 2017, an estimated $1.55M.
Amicus Therapeutics made up 0.04% of Janus Henderson Investors US's portfolio in Q1 2017, its #443 holding.
Janus Henderson Investors US first reported a position in Amicus Therapeutics in Q2 2015 and has held it in 8 quarters since.
Janus Henderson Investors US's Amicus Therapeutics position peaked at $59.5M in Q3 2015.
134 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.